{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:13:08Z","timestamp":1789398788038,"version":"build-2803163510"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    remains a significant cause of nosocomial infections, with increasing antifungal resistance posing a global health challenge. Current therapies, including azoles, echinocandins, and polyenes, are increasingly limited by evolving resistance mechanisms such as efflux pump overexpression and ergosterol pathway mutations. This review explores the potential of RNA interference (RNAi) as a novel therapeutic strategy against drug-resistant\n                    <jats:italic>C. albicans.<\/jats:italic>\n                    While RNAi has shown efficacy in other fungal pathogens, its application in\n                    <jats:italic>C. albicans<\/jats:italic>\n                    is still in early stages. We discuss established antifungal targets, introduce emerging RNAi-based gene silencing approaches, and highlight potential molecular targets including\n                    <jats:italic>ERG1<\/jats:italic>\n                    ,\n                    <jats:italic>ERG6<\/jats:italic>\n                    ,\n                    <jats:italic>ERG11<\/jats:italic>\n                    ,\n                    <jats:italic>CDR1<\/jats:italic>\n                    ,\n                    <jats:italic>CDR2<\/jats:italic>\n                    ,\n                    <jats:italic>CLB2<\/jats:italic>\n                    , and\n                    <jats:italic>GSC1<\/jats:italic>\n                    . RNAi offers a transformative route to overcome resistance at the transcriptional level, bypassing post-translational mutation-related failures of conventional drugs. With advances in small-interfering RNA (siRNA) design, chemical modifications, and nanoparticle delivery systems, RNA-based therapeutics may reshape the future of antifungal treatment.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2025.1675921","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:22:06Z","timestamp":1763619726000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Overcoming antifungal resistance in Candida albicans via RNA interference: a therapeutic perspective"],"prefix":"10.3389","volume":"15","author":[{"given":"Akshay Kisan","family":"Mundhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rajkumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10096-010-1050-8","article-title":"Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida","volume":"30","author":"Ahmad","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-3-030-76320-6_5","article-title":"Antifungal drugs: mechanism of action and resistance","volume-title":"Biochemistry of drug resistance.","author":"Ahmed","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12879-019-4710-z","article-title":"Antifungal resistance in patients with Candidaemia: a retrospective cohort study","volume":"20","author":"Aldardeer","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B5","volume-title":"Application of antisense oligonucleotides to prevent","author":"Ara\u00fajo","year":"2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1093\/jac\/dky302","article-title":"Activity of novel antifungal compound APX001A against a large collection of Candida auris","volume":"73","author":"Berkow","year":"2018","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.mib.2006.10.007","article-title":"Morphogenesis and cell cycle progression in Candida albicans","volume":"9","author":"Berman","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"B8","first-page":"2849","article-title":"The Nobel Prize in Physiology or Medicine for 2006 for the discovery of RNA interference","volume":"150","author":"Bernards","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"B9","doi-asserted-by":"publisher","first-page":"foac019","DOI":"10.1093\/femsyr\/foac019","article-title":"The effect of antifungal resistance development on the virulence of Candida species","volume":"22","author":"Bohner","year":"2022","journal-title":"FEMS Yeast Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J. fungi (Basel Switzerland)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.tim.2021.09.007","article-title":"RNA-based therapeutics to treat human fungal infections","volume":"30","author":"Bruch","year":"2022","journal-title":"Trends Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/ajt.15689","article-title":"RNA interference therapeutics in organ transplantation: The dawn of a new era","volume":"20","author":"Br\u00fcggenwirth","year":"2020","journal-title":"Am. J. Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/jof6040321","article-title":"Amphotericin B and other polyenes-discovery, clinical use, mode of action and drug resistance","volume":"6","author":"Carolus","year":"2020","journal-title":"J. Fungi (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02162","article-title":"Candida albicans and staphylococcus species: A threatening twosome","volume":"10","author":"Carolus","year":"2019","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1634\/theoncologist.5-2-120","article-title":"New drugs and novel targets for treatment of invasive fungal infections in patients with cancer","volume":"5","author":"Chiou","year":"2000","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbrc.2006.02.049","article-title":"Chemical modification of siRNAs to improve serum stability without loss of efficacy","volume":"342","author":"Choung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/pathogens10070859","article-title":"From jekyll to hyde: the yeast-hyphal transition of candida albicans","volume":"10","author":"Chow","year":"2021","journal-title":"Pathogens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1128\/AAC.31.11.1775","article-title":"Synergistic action of amphotericin B and rifampin against Rhizopus species","volume":"31","author":"Christenson","year":"1987","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/myc.13177","article-title":"Attributable mortality of candidemia after introduction of echinocandins","volume":"63","author":"Cornely","year":"2020","journal-title":"Mycoses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/microorganisms8020154","article-title":"Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal","volume":"8","author":"Costa-de-Oliveira","year":"2020","journal-title":"Microorganisms"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00170","article-title":"MicroRNA regulation of host immune responses following fungal exposure","volume":"9","author":"Croston","year":"2018","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","article-title":"In vitro activity of terpenes against Candida biofilms","volume":"31","author":"Dalleau","year":"2008","journal-title":"Int. J. antimicrobial Agents"},{"key":"B24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jgar.2020.06.025","article-title":"Echinocandin resistance in Candida parapsilosis sensu stricto: Role of alterations in CHS3, FKS1 and Rho gene expression","volume":"22","author":"Davari","year":"2020","journal-title":"J. Global Antimicrobial Resistance"},{"key":"B25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12906-015-0947-2","article-title":"Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study","volume":"15","author":"De Castro","year":"2015","journal-title":"BMC complementary Altern. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/ijms17081252","article-title":"Essential oil of Cymbopogon nardus (L.) Rendle: A strategy to combat fungal infections caused by Candida species","volume":"17","author":"De Toledo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40588-020-00151-7","article-title":"Role of non-coding RNAs in fungal pathogenesis and antifungal drug responses","volume":"7","author":"Dhingra","year":"2020","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00807","DOI":"10.1128\/aac.00807-19","article-title":"The siderophore transporter Sit1 determines susceptibility to the antifungal VL-2397","volume":"63","author":"Dietl","year":"2019","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.48.6.2223-2227.2004","article-title":"Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans","volume":"48","author":"Dodgson","year":"2004","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.21236\/ADA392561","volume-title":"Development and use of novel tools to directly screen for substrates of cyclin dependent kinases","author":"Donovan","year":"2000"},{"key":"B31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.1176945","article-title":"RNAi in budding yeast","volume":"326","author":"Drinnenberg","year":"2009","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01182","article-title":"The clinical application of microRNAs in infectious disease","volume":"8","author":"Drury","year":"2017","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/08959374000140010201","article-title":"Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva","volume":"14","author":"Edgerton","year":"2000","journal-title":"Adv. Dental Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/jof7010024","article-title":"Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review","volume":"7","author":"Espinel-Ingroff","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.9734\/jamb\/2020\/v20i930281","article-title":"Antifungal resistance pattern of Candida species isolated from high vaginal swabs of women attending a hospital in Enugu State, Nigeria","volume":"20","author":"Ezeadila","year":"2020","journal-title":"J. Adv. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"B37","first-page":"2773","article-title":"Prevalence of vaginal candidiasis infection in diabetic women","volume":"6","author":"Faraj\u0131","year":"2011","journal-title":"Afr J. Microbiol. Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00002","article-title":"The antifungal activity of lactoferrin and its derived peptides: mechanisms of action and synergy with drugs against fungal pathogens","volume":"8","author":"Fernandes","year":"2017","journal-title":"Front. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of Candida albicans","volume":"4","author":"Ford","year":"2015","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.18781\/R.MEX.FIT.2005-6","article-title":"Lysozymes: characteristics, mechanism of action and technological applications on the control of pathogenic microorganisms","volume":"38","author":"G\u00e1lvez-Iriqui","year":"2020","journal-title":"Rev. mexicana fitopatolog\u00eda"},{"key":"B42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/jof6040262","article-title":"Rezafungin\u2014mechanisms of action, susceptibility and resistance: similarities and differences with the other echinocandins","volume":"6","author":"Garcia-Effron","year":"2020","journal-title":"J. fungi"},{"key":"B43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/plants10040650","article-title":"RNA interference strategies for future management of plant pathogenic fungi: Prospects and challenges","volume":"10","author":"Gebremichael","year":"2021","journal-title":"Plants"},{"key":"B44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.fbr.2021.09.003","article-title":"The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19","volume":"38","author":"Ghosh","year":"2021","journal-title":"Fungal Biol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jez.b.23009","article-title":"System-level analyses of keystone genes required for mammalian tooth development","volume":"336","author":"Hallikas","year":"2021","journal-title":"J. Exp. Zoology Part B: Mol. Dev. Evol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B48","first-page":"101","article-title":"Antifungal effect of Cuminum cyminum extract on Candida albicans ATCC 10231 (Experimental laboratory)","volume":"12","author":"Hartini","year":"2019","journal-title":"J. Int. Dental Med. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.44.10.2693-2700.2000","article-title":"Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors","volume":"44","author":"Henry","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e01623","DOI":"10.1128\/aac.01623-22","article-title":"Safety and pharmacokinetics of intravenous and oral fosmanogepix, a first-in-class antifungal agent, in healthy volunteers","volume":"67","author":"Hodges","year":"2023","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","article-title":"Molecular mechanisms of primary resistance to flucytosine in Candida albicans","volume":"48","author":"Hope","year":"2004","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e2315926121","DOI":"10.1073\/pnas.2315926121","article-title":"Identification of an active RNAi pathway in Candida albicans","volume":"121","author":"Iracane","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ph14010027","article-title":"Flavones, flavonols, and glycosylated derivatives-impact on candida albicans growth and virulence, expression of CDR1 and ERG11, cytotoxicity","volume":"14","author":"Ivanov","year":"2020","journal-title":"Pharm. (Basel)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s12013-024-01599-w","article-title":"Impact of ERG6 gene deletion on membrane composition and properties in the pathogenic yeast Candida glabrata","volume":"83","author":"Jacko","year":"2025","journal-title":"Cell Biochem. Biophysics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1586\/eri.11.152","article-title":"Candida albicans dimorphism as a therapeutic target","volume":"10","author":"Jacobsen","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3390\/molecules26113476","article-title":"Investigation of antifungal mechanisms of thymol in the human fungal pathogen, Cryptococcus neoformans","volume":"26","author":"Jung","year":"2021","journal-title":"Molecules"},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/mt.2012.7","article-title":"Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin","volume":"20","author":"Karik\u00f3","year":"2012","journal-title":"Mol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e01134","DOI":"10.1128\/aac.01134-18","article-title":"Crystal structures of full-length lanosterol 14\u03b1-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery","volume":"62","author":"Keniya","year":"2018","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3109\/13880209.2014.900808","article-title":"Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans","volume":"52","author":"Khodavandi","year":"2014","journal-title":"Pharm. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cbdv.201600070","article-title":"Chemical composition and biological activity of Centaurea baseri: new species from Turkey","volume":"13","author":"K\u00f6se","year":"2016","journal-title":"Chem. biodiversity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acsinfecdis.5b00134","article-title":"Antitumor\/antifungal celecoxib derivative AR-12 is a non-nucleoside inhibitor of the ANL-family adenylating enzyme acetyl CoA synthetase","volume":"2","author":"Koselny","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1128\/AAC.00470-08","article-title":"Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3","volume":"53","author":"Krishnakumari","year":"2009","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B64","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12223-020-00785-6","article-title":"Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana","volume":"65","author":"Kumar","year":"2020","journal-title":"Folia Microbiol. (Praha)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/jac\/dku549","article-title":"Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species","volume":"70","author":"Lamoth","year":"2015","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"B66","doi-asserted-by":"publisher","first-page":"9348","DOI":"10.3390\/ijms21249348","article-title":"The evolutionary significance of RNAi in the fungal kingdom","volume":"21","author":"Lax","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-319-39496-1_14","article-title":"Human fungal infections: emerging role of small non-coding RNAs as modulators of host-pathogen interactions","author":"Leit\u00e3o","year":"2016","journal-title":"Non-coding RNAs and Inter-kingdom Communication"},{"key":"B68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","article-title":"RNA interference: from gene silencing to gene-specific therapeutics","volume":"107","author":"Leung","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/10412905.2012.754728","article-title":"Antifungal activity and mode of action of carvacrol against Candida albicans strains","volume":"25","author":"Lima","year":"2013","journal-title":"J. essential Oil Res."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150859","article-title":"Synergistic effect of fluconazole and calcium channel blockers against resistant Candida albicans","volume":"11","author":"Liu","year":"2016","journal-title":"PloS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1128\/AAC.01324-10","article-title":"Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis","volume":"55","author":"Louie","year":"2011","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B72","doi-asserted-by":"publisher","first-page":"myac095","DOI":"10.1093\/mmy\/myac095","article-title":"RNAi machinery regulates nutrient metabolism and fluconazole resistance in the pathogenic fungus Cryptococcus deneoformans","volume":"61","author":"Ma","year":"2022","journal-title":"Med. Mycology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/abr.abr_214_19","article-title":"Identification of candida species and antifungal susceptibility in cancer patients with oral lesions in ahvaz, southern west of Iran","volume":"9","author":"Maheronnaghsh","year":"2020","journal-title":"Advanced Biomed. Res."},{"key":"B74","first-page":"117","article-title":"Terbinafine induced stevens johnson syndrome toxic epidermal necrolysis overlap syndrome","volume":"6","author":"Matpathi","year":"2023","journal-title":"Asian J. Case Rep. Med. Health"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1128\/MMBR.62.4.1191-1243.1998","article-title":"Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae","volume":"62","author":"Mendenhall","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11046-012-9539-6","article-title":"RNA-mediated gene silencing in Candida albicans: inhibition of hyphae formation by use of RNAi technology","volume":"174","author":"Moazeni","year":"2012","journal-title":"Mycopathologia"},{"key":"B78","first-page":"172","article-title":"Down-regulation of the ALS3 gene as a consequent effect of RNA-mediated silencing of the EFG1 gene in Candida albicans","volume":"16","author":"Moazeni","year":"2012","journal-title":"Iranian Biomed. J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6091\/ibj.1093.2012","article-title":"The effect of EFG1 gene silencing on down-regulation of SAP5 gene, by use of RNAi technology","volume":"52","author":"Moazeni","year":"2014","journal-title":"Acta Med. Iranica"},{"key":"B80","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/myc.12417","article-title":"cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus","volume":"58","author":"Mousavi","year":"2015","journal-title":"Mycoses"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00629","article-title":"Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition","volume":"8","author":"Mukaremera","year":"2017","journal-title":"Front. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e01176","DOI":"10.1016\/j.idcr.2021.e01176","article-title":"A case of candidemia after long-term presence of urethral foreign bodies","volume":"25","author":"Nagata","year":"2021","journal-title":"IDCases"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2153086","DOI":"10.1080\/22221751.2022.2153086","article-title":"Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China","volume":"12","author":"Ning","year":"2023","journal-title":"Emerging Microbes Infections"},{"key":"B85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance","volume":"5","author":"Prasad","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.4317\/medoral.22978","article-title":"Therapeutic tools for oral candidiasis: Current and new antifungal drugs","volume":"24","author":"Quind\u00f3s","year":"2019","journal-title":"Med. Oral. Patol Oral. Cir Bucal"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.6.11.2021","article-title":"Cyclin-B homologs in Saccharomyces cerevisiae function in S phase and in G2","volume":"6","author":"Richardson","year":"1992","journal-title":"Genes Dev."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.605711","article-title":"Transcriptional circuits regulating developmental processes in candida albicans","volume":"10","author":"Rodriguez","year":"2020","journal-title":"Front. Cell. Infection Microbiol."},{"key":"B91","first-page":"39","article-title":"Molecular mechanisms of resistance to antifungals in Candida albicans","author":"Ruiz-Baca","year":"2021","journal-title":"Adv. Candida albicans"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1009564","DOI":"10.1371\/journal.ppat.1009564","article-title":"The role of aneuploidy in the emergence of echinocandin resistance in human fungal pathogen Candida albicans","volume":"17","author":"Sah","year":"2021","journal-title":"PloS Pathog."},{"key":"B93","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1699-0463.1997.tb05097.x","article-title":"The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans","volume":"105","author":"Samaranayake","year":"1997","journal-title":"Apmis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e01102","DOI":"10.1128\/aac.01102-17","article-title":"Antifungal activity of SCY-078 and standard antifungal agents against 178 clinical isolates of resistant and susceptible Candida species","volume":"61","author":"Schell","year":"2017","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymeth.2007.09.006","article-title":"Real-time PCR quantification of precursor and mature microRNA","volume":"44","author":"Schmittgen","year":"2008","journal-title":"Methods"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1099\/jmm.0.047852-0","article-title":"In vitro antifungal activity of the flavonoid baicalein against Candida species","volume":"61","author":"Serpa","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"20499361231161387","DOI":"10.1177\/20499361231161387","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"232","DOI":"10.17749\/2313-7347\/ob.gyn.rep.2024.500","article-title":"Reviewing the mechanism of action and results of clinical studies on the antifungal drug ibrexafungerp","volume":"18","author":"Tagirova","year":"2024","journal-title":"Obstetrics Gynecology Reprod."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"J. antibiotics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"128013","DOI":"10.1016\/j.bmcl.2021.128013","article-title":"Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans","volume":"41","author":"Teymuri","year":"2021","journal-title":"Bioorganic Medicinal Chem. Lett."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e00111","DOI":"10.1128\/cmr.00111-18","article-title":"Candida parapsilosis: from genes to the bedside","volume":"32","author":"T\u00f3th","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/antibiotics9080445","article-title":"Current antimycotics, new prospects, and future approaches to antifungal therapy","volume":"9","author":"Wall","year":"2020","journal-title":"Antibiotics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s13346-013-0161-z","article-title":"Lipid nanoparticle delivery systems for siRNA-based therapeutics","volume":"4","author":"Wan","year":"2014","journal-title":"Drug Delivery Transl. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in candida albicans and emerging non-albicans candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/00222615-48-8-721","article-title":"Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme","volume":"48","author":"Wu","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/s41467-025-60423-y","article-title":"Mechanisms of aureobasidin A inhibition and drug resistance in a fungal IPC synthase complex","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e00374","DOI":"10.1128\/aac.00374-19","article-title":"The novel arylamidine T-2307 selectively disrupts yeast mitochondrial function by inhibiting respiratory chain complexes","volume":"63","author":"Yamashita","year":"2019","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21505594.2022.2119656","article-title":"Nicotinamide potentiates amphotericin B activity against Candida albicans","volume":"13","author":"Yan","year":"2022","journal-title":"Virulence"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1675921\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:22:09Z","timestamp":1763619729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1675921\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":111,"alternative-id":["10.3389\/fcimb.2025.1675921"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1675921","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1675921"}}